EJCTS Click here to go to Siemens website
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zund, G.
Right arrow Articles by Vacanti, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zund, G.
Right arrow Articles by Vacanti, J. P.

European Journal of Cardio-Thoracic Surgery, Vol 11, 493-497, Copyright © 1997 by European Association for Cardio-thoracic Surgery


ARTICLES

The in vitro construction of a tissue engineered bioprosthetic heart valve

G Zund, CK Breuer, T Shinoka, PX Ma, R Langer, JE Mayer and JP Vacanti
Department of Cardiac Surgery, Children's Hospital, Harvard Medical School, Boston MA 02115, USA.

PROBLEM: Heart valve replacement with either a nonliving xenograft or a mechanical prosthesis is an effective therapy for valvular heart disease. Both of these approaches have limitations, including their inability to grow, repair, and remodel. In addition, a mechanical prosthesis requires long-term anticoagulation therapy. METHODS: This study demonstrates the in vitro creation of tissue engineered heart valve tissue using cardiovascular cells on degradable polymer matrices, 40 heart valve leaflets were created using this technique from two sources. Xenograft leaflets were created using human dermal fibroblasts and bovine aortic endothelial cells (n = 20) or allograft valve leaflets were created using sheep myofibroblasts and sheep endothelial cells (n = 20). A mixed sheep cell population was obtained consisting of endothelial cells and myofibroblasts. Endothelial cells were labelled with acethylated low density lipoprotein (Ac-Dil-LDL) and cells were separated into two groups using an activated cell sorter: LDL positive cells comprised of a pure endothelial cell population and LDL negative cells comprised of mixed cell population containing myofibroblasts and smooth muscle cells. The LDL negative cells were seeded on a synthetic polyglycolic acid (PGA) mesh and grown in vitro to form a tissue-like fibroblast-mesh core. Endothelial cells were then seeded onto the surface of the fibroblast-mesh core, forming a single monolayer. RESULTS: Histological evaluation of these constructs revealed an inner core of LDL negative cells and outer endothelial-like cells which were factor VIII positive. There was no evidence of capillary formation from endothelial cells invading the myofibroblasts and smooth muscle matrix and the endothelial lining appeared complete. CONCLUSIONS: It is feasible to construct allogenic heart valve tissue which could be used to make a valve.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
R. Sodian, C. Lueders, L. Kraemer, W. Kuebler, M. Shakibaei, B. Reichart, S. Daebritz, and R. Hetzer
Tissue Engineering of Autologous Human Heart Valves Using Cryopreserved Vascular Umbilical Cord Cells
Ann. Thorac. Surg., June 1, 2006; 81(6): 2207 - 2216.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. Bertipaglia, F. Ortolani, L. Petrelli, G. Gerosa, M. Spina, P. Pauletto, D. Casarotto, M. Marchini, and S. Sartore
Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur)
Ann. Thorac. Surg., April 1, 2003; 75(4): 1274 - 1282.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. R. Clarke
Presidential address: Value, viability, and valves
J. Thorac. Cardiovasc. Surg., July 1, 2002; 124(1): 1 - 6.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
K. L. Weind, C. G. Ellis, and D. R. Boughner
Aortic valve cusp vessel density: Relationship with tissue thickness
J. Thorac. Cardiovasc. Surg., February 1, 2002; 123(2): 333 - 340.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. L. Weind, D. R. Boughner, L. Rigutto, and C. G. Ellis
Oxygen diffusion and consumption of aortic valve cusps
Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2604 - H2611.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. R. Fuchs, B. A. Nasseri, and J. P. Vacanti
Tissue engineering: a 21st century solution to surgical reconstruction
Ann. Thorac. Surg., August 1, 2001; 72(2): 577 - 591.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Jockenhoevel, G. Zund, S. P. Hoerstrup, K. Chalabi, J. S. Sachweh, L. Demircan, B. J. Messmer, and M. Turina
Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering
Eur. J. Cardiothorac. Surg., April 1, 2001; 19(4): 424 - 430.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. A. Folliguet, C. Rucker-Martin, C. Pavoine, E. Deroubaix, M. Henaff, J.-J. Mercadier, and S. N. Hatem
Adult cardiac myocytes survive and remain excitable during long-term culture on synthetic supports
J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 510 - 519.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. Sodian, S. P. Hoerstrup, J. S. Sperling, S. H. Daebritz, D. P. Martin, F. J. Schoen, J. P. Vacanti, and J. E. Mayer Jr
Tissue engineering of heart valves: in vitro experiences
Ann. Thorac. Surg., July 1, 2000; 70(1): 140 - 144.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Q. Ye, G. Zund, P. Benedikt, S. Jockenhoevel, S. P. Hoerstrup, S. Sakyama, J. A. Hubbell, and M. Turina
Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering
Eur. J. Cardiothorac. Surg., May 1, 2000; 17(5): 587 - 591.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
Q. Ye, G. Zund, S. Jockenhoevel, S. P. Hoerstrup, A. Schoeberlein, J. Grunenfelder, and M. Turina
Tissue engineering in cardiovascular surgery: new approach to develop completely human autologous tissue
Eur. J. Cardiothorac. Surg., April 1, 2000; 17(4): 449 - 454.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. P. Hoerstrup, G. Zund, A. Schoeberlein, Q. Ye, P. R. Vogt, and M. I. Turina
Fluorescence activated cell sorting: A reliable method in tissue engineering of a bioprosthetic heart valve
Ann. Thorac. Surg., November 1, 1998; 66(5): 1653 - 1657.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Zund, S. P. Hoerstrup, A. Schoeberlein, M. Lachat, G. Uhlschmid, P. R. Vogt, and M. Turina
Tissue engineering: A new approach in cardiovascular surgery; Seeding of human fibroblasts followed by human endothelial cells on resorbable mesh
Eur. J. Cardiothorac. Surg., February 1, 1998; 13(2): 160 - 164.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1997 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.